Title: Re: phenergan
While there are numerous lawsuits involving promethazine injuries, there is not much that has ever been published. The following are the only ones that I know of:
Extravasation of I.V. promethazine      M. Malesker, P. Malone, C. Cingle, R. Cochran   American journal of health-System pharmacy      unusual drug experiences, FDA, promethazine injection, intra-arterial injection, extravasation, dominal hysterectomy    05-14-01        Vol. 56, September 1, 1999      1742-1743       2049    Case Report

Accidental intra-arterial injection of promethazine HCI during general anesthesia: report of a case     H. Mostafavi, M. Samimi Anesthesiology  intra-arterial injection, promethazine hydrochloride (Phenergan), anesthesia    10-30-02        Vol. 35, No. 6, December 1971   645-646 2836    Case Report

Promethazine adverse events after implementation of a medication shortage interchange.  H. Sheth, M. Verrico, S. Skedar, A. Towers      Ann Pharmacother        promethazine, adverse events,   11-11-5 Volume 39, Number 2, February 2005      255-261 5265    Abstract

Adverse reactions related to phenergan  C. Blankenship  Gastroenterology Nursing        Phenergan, arterial misplacement, PICC, pediatrics, seizure activity    11-04-04        Volume 24, Number 3     149-150 3985    Review

At 5:23 PM -0800 2/28/06, Kilbourne, Susan wrote:
We are finally having a team meeting at our hospital to discuss the use of IV phenergan through peripheral lines after having two problems in the past year. The problem is convincing the MDs. Can anyone point me to some specific literature to support of dangers of infiltrated phenergan?
Thanks in advance,
Sue Kilbourne CRNI, OCN



NOTE: The information contained in this message may be privileged and confidential and protected from disclosure. If the reader of this message is not the intended recipient, or an employee or agent responsible for delivering this message to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify us immediately by replying to the message and deleting it from your computer.
E-mail has the potential to have been altered or corrupted due to transmission or conversion. It may not be appropriate to rely upon this E-mail in the same manner as hardcopy materials bearing the author's original signature or seal. Thank you. AsanteĀ® Health System


--
Lynn Hadaway, M.Ed., RNC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
http://www.hadawayassociates.com
office 770-358-7861



Reply via email to